Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × SHR-1701 × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma 1 Gastric Adenocarcinoma 1

Interventions

Oxaliplatin 27 pembrolizumab 22 Fluorouracil 19 Capecitabine 17 Leucovorin 14 Nivolumab 13 Trastuzumab 10 Paclitaxel 7 trastuzumab deruxtecan 6 Specimen Handling 6 S 1 (combination) 6 Irinotecan 6 Docetaxel 6 Cisplatin 6 durvalumab 5 Drug Therapy 5 Bevacizumab 5 zolbetuximab 4 zimberelimab 4 atezolizumab 4 apatinib 4 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 Carboplatin 4 Biopsy 4 zanidatamab 3 olaparib 3 fludarabine 3 avelumab 3 XELOX 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07311408 2025-12-31

SHR-2554

China Medical University, China

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡